John Peck
Directeur/Bestuurslid bij Batu Biologics, Inc.
Vermogen: 227 283 $ op 30-04-2024
Profiel
John Peck is currently a Director at Batu Biologics, Inc. He holds an MBA from DePaul University and an undergraduate degree from Northern Illinois University, which he received in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2023 | 227 283 333 ( 5.37% ) | 227 283 $ | 30-04-2024 |
Actieve functies van John Peck
| Bedrijven | Functie | Begin |
|---|---|---|
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 24-02-2017 |
Opleiding van John Peck
| Northern Illinois University | Undergraduate Degree |
| DePaul University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Health Technology |
